Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04491292

Conditions

COVID-19 Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Questionnaire Administration

Study Details

Brief summary:

This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems. Assessing how the pandemic is affecting employees may allow for more comprehensive actions to be taken to protect the mental health of employees.

Conditions

COVID-19 Infection

Study ID

NCT04491292

Start date

May 18, 2020

Status verified date

Jul, 2026

Completion date

Apr 30, 2028

Anticipated

Primary completion date

Apr 30, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • MD Anderson employees

Study Design

Enrollment

20000 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (questionnaire)

Participants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.

Interventions

Questionnaire Administration

Complete questionnaires

Primary outcome measure

  • Change in psychosocial outcomes [ Time Frame: Baseline up to 3 months after the outbreak ends ]
  • Change in stress-related outcomes [ Time Frame: Baseline up to 3 months after the outbreak ends ]

Central Contacts and Locations

Central contacts

Priya R. Bhosale

713-792-0221priya.bhosale@mdanderson.org

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Priya R. Bhosale

713-792-0221priya.bhosale@mdanderson.org

Principal Investigator:

Priya R. Bhosale

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jul 22, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-07-22.